World
Merck and Moderna: mRNA melanoma vaccine extends remission in key study
Merck and Moderna announced positive initial phase three results for a melanoma vaccine, with shares of both companies rising in premarket trading.
AI
AI and Mini Brains Are Changing How Future Medicines Are Made
From lab-grown brain tissues to autonomous AI systems for molecule design, the pharmaceutical industry is undergoing a profound transformation. McKinsey estimates that generative AI could shorten the drug discovery process by as much as 50 percent.